Janux Therapeutics. Every tracked FinTwit mention of $JANX, newest first. 12 mentions since the first on Jul 25, 2025. See the price chart.
March 2026 · 2 mentions
Mar 16
Jacob Plieth — $CTMX efficacy wanes, but varseta-M still looks good. Shares +64% now! Via @ApexOnco -> https://t.co/PLy2CGE6lr $JANX↗
Mar 4
Jacob Plieth — $CTMX, +660% in 12 months, approaches its masked ADC catalyst. Via @ApexOnco -> https://t.co/oQI1iQiV4N ( $JANX -58% in the same timeframe)↗
Jacob Plieth — $JANX ended -53%, $CTMX -11%. Here's yesterday's take from @ByMadeleineA at @ApexOnco https://t.co/5cQ4Xw32YM↗
Dec 2
Jacob Plieth — @STL_Biotech That CRS prophylaxis tidbit might be the most deranged aspect of today's $JANX collapse. Wild!↗
Dec 2
Jacob Plieth — A year ago we were warning you that $JANX was cherrypicking data. It all seems to be unravelling today, stock -50%↗
November 2025 · 1 mention
Nov 17
Jacob Plieth — $JNJ just acquired Halda for $3.05bn. Earlier story from @BatirtzeAreitio -> https://t.co/7nxuN3Oykj $JANX $CTMX↗
August 2025 · 1 mention
Aug 13
Jacob Plieth — So all good still for $CTMX varsetatug masetecan (CX-2051)? Additional ph1 data by Q1 2026 is in line with January disclosure. What "recent social media posts" are they referring t…↗
July 2025 · 2 mentions
Jul 25
Jacob Plieth — $JANX resurrects a TROP2 asset, and continues tinkering with CD28. Meanwhile, JANX007 & JANX008 data are a waiting game. Via @ApexOnco -> https://t.co/kqO2x7AYOv $CTMX↗
Jul 25
Jacob Plieth — So about $JANX introducing a TROP2 project to the pipeline... here's what it said in its S-1 in 2021 https://t.co/XtRXHCT1SC↗
Dec 1
Adam Feuerstein ✡️ — Wait... I thought biotech stock prices only go up? $JANX↗